Insurers fail to keep up with speech technology, deny funding for devices that multi-task

Insurance companies push speech-impaired patients, like one New York woman with ALS, or Lou Gehrig's disease, to buy expensive computers featuring text-to-speech software by refusing to pay for alternative devices, the New York Times reports. Furthermore, they insist on blocking all other capabilities of the proprietary machines they do cover. In the case of Kara Lynn, the ALS patient, a $300 iPhone with an added $150 software program does the job at a fraction of the price. The computers that insurers want her to buy could cost 10 to 20 times as much, and the manufacturers mark up the products by up to 2,000 percent.

"We would not cover the iPhones and netbooks with speech-generating software capabilities because they are useful in the absence of an illness or injury," said Peter Ashkenaz, a spokesperson for the government agency that runs Medicare. Private companies share that rationale. The case highlights the failure of policymakers and the health care industry at large to keep up with "Moore's Law, the principle that computing power rapidly increases even as costs fall sharply," the Times reports.

Another key example is that doctors don't get paid for examining photos of rashes e-mailed in or having phone calls with patients. The patient must come to the doctors office in order for most insurers to pay (Vance, 9/14).

This is part of Kaiser Health News' Daily Reports - a summary of health policy coverage from more than 300 news organizations. The full summary of the day's news can be found here and you can sign up for e-mail subscriptions to the Daily Reports here. In addition, our staff of reporters and correspondents file original stories each day, which you can find on our home page.


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Human midbrain organoids: A promising tool in the fight against Parkinson's disease